Moreover, naringin inhibited cell migration and invasion of chondrosarcoma cells via vascular cell adhesion molecule 1 (VCAM-1) down-regulation by increasing miR-126 [186], while in bladder cancer cells it downregulated the Akt and MMP-2 pathways [187]. This evidence concerns the gene VCAM1 and urinary bladder cancer.